KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to -$34.8 million.

  • Evolent Health's Net Cash Flow fell 24533.62% to -$34.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year increase of 11610.8%. This contributed to the annual value of -$44.7 million for FY2024, which is 63392.22% down from last year.
  • As of Q3 2025, Evolent Health's Net Cash Flow stood at -$34.8 million, which was down 24533.62% from -$99.8 million recorded in Q2 2025.
  • Evolent Health's 5-year Net Cash Flow high stood at $99.3 million for Q1 2025, and its period low was -$99.8 million during Q2 2025.
  • Over the past 5 years, Evolent Health's median Net Cash Flow value was -$1.0 million (recorded in 2023), while the average stood at -$11.4 million.
  • In the last 5 years, Evolent Health's Net Cash Flow crashed by 481419.25% in 2021 and then skyrocketed by 506392.96% in 2024.
  • Over the past 5 years, Evolent Health's Net Cash Flow (Quarter) stood at $73.2 million in 2021, then tumbled by 72.15% to $20.4 million in 2022, then tumbled by 105.02% to -$1.0 million in 2023, then skyrocketed by 5063.93% to $50.8 million in 2024, then tumbled by 168.46% to -$34.8 million in 2025.
  • Its Net Cash Flow stands at -$34.8 million for Q3 2025, versus -$99.8 million for Q2 2025 and $99.3 million for Q1 2025.